New ACOG guidelines on progesterone to prevent preterm birth praised by March of Dimes

WHITE PLAINS, N.Y., NOV. 5, 2003 -- The latest research shows that some women at very high risk of having a preterm baby may benefit from treatment with a derivative of the hormone progesterone, according to an opinion issued by the American College of Obstetricians and Gynecologists (ACOG) Committee on Obstetric Practice and published this month in ACOG's official journal, Obstetrics & Gynecology.

However, the ACOG Committee said further studies are needed to evaluate the value of progesterone further and resolve issues such as the optimal route of drug delivery.

"Prematurity is the number one health problem for babies in the United States today," said Nancy S. Green, M.D., medical director of the March of Dimes. "The March of Dimes is encouraged by the preliminary results of the studies of progesterone to prevent preterm birth, and we look forward to more research to help us understand which women would be most likely to respond to this treatment."

Dr. Green said progesterone treatment could be a potential step toward reducing the growing rate of premature birth in the United States, which has risen 27 percent since 1981. In 2001, more than 476,000 babies, or about 12 percent of live births, were born prematurely (before 37 weeks gestation). In January 2003, the March of Dimes launched a campaign to help increase public awareness of the serious and common problem of prematurity and decrease the rate of premature birth.

The ACOG Committee urges physicians to restrict the use of progesterone only to pregnant women with a documented history of a previous spontaneous preterm birth, as this was the population studied in the two separate randomized clinical trials cited. In the study by Meis et al. (N. Engl. J. Med. 2003;348:2379-85), treatment with progesterone reduced the risk of preterm birth by about one-third. In the study by da Fonseca et al. (Am. J. Obstet. Gynecol. 2003;188:419-24), the rate of preterm delivery was reduced by

Contact: Michele Kling
March of Dimes Birth Defects Foundation

Page: 1 2

Related biology news :

1. New guidelines show significant benefits of FUZEON for wide range of pre-treated HIV/AIDS patients
2. International critical care doctors release first-ever guidelines for sepsis
3. Revised guidelines published for testing for hereditary type of colorectal cancer
4. Ethical guidelines needed before nutrigenomic groceries come to market
5. New guidelines can help health officials better predict and control dengue epidemics
6. Researchers develop guidelines to establish identity of genes responsible for complex diseases
7. Aborigine study suggests body mass index guidelines should be lower to block diabetes
8. New nutrition guidelines for diabetics promote emphasis on high-monounsaturated fat diet
9. Conservation International and Starbucks announce new coffee sourcing guidelines
10. Report on dietary supplements containing ephedra makes urgent call for research to develop dose guidelines, safety warnings
11. Current HIV treatment guidelines may result in more men than women being eligible for treatment

Post Your Comments:

(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ca (PRWEB) , ... October 12, 2017 , ... ... the Surgical Wound Market with the addition of its newest module, US Hemostats ... $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced that ... SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 ... cross the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation ...
Breaking Biology Technology:
Cached News: